A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen—positive chronic hepatitis B
…, N Leung, EK Teo, M Tong, F Wong, HW Hann, S Han… - Gastroenterology, 2005 - Elsevier
Background & Aims: A previous 4-week trial of telbivudine in patients with chronic hepatitis B
indicated marked antiviral effects with good tolerability, leading to the present 1-year phase …
indicated marked antiviral effects with good tolerability, leading to the present 1-year phase …
The management of chronic hepatitis B in Asian Americans
…, CQ Pan, HW Hann, KV Kowdley, SHB Han… - Digestive diseases and …, 2011 - Springer
Hepatitis B virus (HBV) infection is common with major clinical consequences worldwide. In
Asian Americans, the HBsAg carrier rate ranges from 7 to 16%; HBV is the most important …
Asian Americans, the HBsAg carrier rate ranges from 7 to 16%; HBV is the most important …
Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus
R Perrillo, H Hann, D Mutimer, B Willems, N Leung… - Gastroenterology, 2004 - Elsevier
Background & Aims : Prolonged lamivudine therapy is associated with treatment-resistant
YMDD mutant hepatitis B virus (HBV). We evaluated the efficacy and safety of adding adefovir …
YMDD mutant hepatitis B virus (HBV). We evaluated the efficacy and safety of adding adefovir …
[HTML][HTML] Then and now: the progress in hepatitis B treatment over the past 20 years
D Halegoua-De Marzio, HW Hann - World Journal of …, 2014 - ncbi.nlm.nih.gov
The ultimate goals of treating chronic hepatitis B (CHB) is prevention of hepatocellular
carcinoma (HCC) and hepatic decompensation. Since the advent of effective antiviral drugs that …
carcinoma (HCC) and hepatic decompensation. Since the advent of effective antiviral drugs that …
[HTML][HTML] Early hepatitis B virus DNA reduction in hepatitis B e antigen–positive patients with chronic hepatitis B: A randomized international study of entecavir versus …
N Leung, CY Peng, HW Hann, J Sollano… - …, 2009 - Wiley Online Library
This study was undertaken to compare the early antiviral activity and viral kinetic profiles of
entecavir (ETV) versus adefovir (ADV) in hepatitis B e antigen positive nucleoside‐naïve …
entecavir (ETV) versus adefovir (ADV) in hepatitis B e antigen positive nucleoside‐naïve …
[HTML][HTML] Alpha-fetoprotein (AFP) and AFP-L3 is most useful in detection of recurrence of hepatocellular carcinoma in patients after tumor ablation and with low AFP …
…, C Roth, M Cohen, D Halegoua-DeMarzio, HW Hann - Viruses, 2022 - mdpi.com
Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and is
a leading cause of mortality worldwide. While there are many risk factors for HCC including …
a leading cause of mortality worldwide. While there are many risk factors for HCC including …
Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B
…, P Kwan, M Fabri, A Horban, M Pelemis, HW Hann… - Gastroenterology, 2014 - Elsevier
Background & Aims Tenofovir disoproxil fumarate (TDF) is active against lamivudine-resistant
hepatitis B virus (HBV) infection, but data to support its clinical efficacy in this setting are …
hepatitis B virus (HBV) infection, but data to support its clinical efficacy in this setting are …
Outcomes of long-term treatment of chronic HBV infection with entecavir or other agents from a randomized trial in 24 countries
JL Hou, W Zhao, C Lee, HW Hann, CY Peng… - Clinical …, 2020 - Elsevier
Background & Aims Treatment of chronic hepatitis B virus (HBV) infection with entecavir
suppresses virus replication and reduces disease progression, but could require life-long …
suppresses virus replication and reduces disease progression, but could require life-long …
[HTML][HTML] Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients
HW Hann, S Wan, RE Myers, RS Hann, J Xing, B Chen… - PloS one, 2012 - journals.plos.org
Background Serum liver enzymes are frequently tested in clinics to aid disease diagnosis.
Large observational studies indicated that these enzymes might predict cancer risk and …
Large observational studies indicated that these enzymes might predict cancer risk and …
[HTML][HTML] Cell-free circulating mitochondrial DNA content and risk of hepatocellular carcinoma in patients with chronic HBV infection
Recent studies have demonstrated a potential link between circulating cell-free mitochondrial
DNA (mtDNA) content and cancers. However, there is no study evaluating the association …
DNA (mtDNA) content and cancers. However, there is no study evaluating the association …